FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225133088> ?p ?o ?g. }

• W4225133088 endingPage "1316" @default.
• W4225133088 startingPage "1313" @default.
• W4225133088 abstract "International Forum of Allergy & RhinologyEarly View RESEARCH NOTE Inhibiting the type 2 inflammatory pathway with dupilumab is associated with an increase in interleukin-4 and interleukin-18 production Jymirah Morris BS, Jymirah Morris BS orcid.org/0000-0003-0245-9117 Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA Jymirah Morris and Tolani F. Olonisakin contributed equally to this work.Search for more papers by this authorTolani F. Olonisakin PhD, Tolani F. Olonisakin PhD orcid.org/0000-0002-8342-3409 Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA Jymirah Morris and Tolani F. Olonisakin contributed equally to this work.Search for more papers by this authorJohn A. Moore BA, John A. Moore BA Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh, Pittsburgh, PASearch for more papers by this authorBaDoi Phan BS, BaDoi Phan BS Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorDana M. Parker BA, Dana M. Parker BA Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorBliss A. Uribe BS, Bliss A. Uribe BS Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorStephanie J. Barel BA, Stephanie J. Barel BA Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorEve M.R. Bowers MD, Eve M.R. Bowers MD Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorKathleen M. Buchheit MD, Kathleen M. Buchheit MD Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, MASearch for more papers by this authorTanya M. Laidlaw MD, Tanya M. Laidlaw MD orcid.org/0000-0001-6709-9795 Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, MASearch for more papers by this authorStella E. Lee MD, Corresponding Author Stella E. Lee MD slee192@bwh.harvard.edu orcid.org/0000-0001-6563-6606 Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA Correspondence Stella E. Lee, MD, Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, Brigham and Women's Hospital, 45 Francis Street, Boston, MA 02115. e-mail: slee192@bwh.harvard.eduSearch for more papers by this author Jymirah Morris BS, Jymirah Morris BS orcid.org/0000-0003-0245-9117 Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA Jymirah Morris and Tolani F. Olonisakin contributed equally to this work.Search for more papers by this authorTolani F. Olonisakin PhD, Tolani F. Olonisakin PhD orcid.org/0000-0002-8342-3409 Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA Jymirah Morris and Tolani F. Olonisakin contributed equally to this work.Search for more papers by this authorJohn A. Moore BA, John A. Moore BA Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh, Pittsburgh, PASearch for more papers by this authorBaDoi Phan BS, BaDoi Phan BS Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorDana M. Parker BA, Dana M. Parker BA Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorBliss A. Uribe BS, Bliss A. Uribe BS Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorStephanie J. Barel BA, Stephanie J. Barel BA Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorEve M.R. Bowers MD, Eve M.R. Bowers MD Department of Otolaryngology-Head & Neck Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PASearch for more papers by this authorKathleen M. Buchheit MD, Kathleen M. Buchheit MD Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, MASearch for more papers by this authorTanya M. Laidlaw MD, Tanya M. Laidlaw MD orcid.org/0000-0001-6709-9795 Division of Allergy and Clinical Immunology, Department of Medicine, Brigham and Women's Hospital Harvard Medical School, Boston, MASearch for more papers by this authorStella E. Lee MD, Corresponding Author Stella E. Lee MD slee192@bwh.harvard.edu orcid.org/0000-0001-6563-6606 Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA Correspondence Stella E. Lee, MD, Division of Otolaryngology-Head & Neck Surgery, Department of Surgery, Brigham and Women's Hospital, 45 Francis Street, Boston, MA 02115. e-mail: slee192@bwh.harvard.eduSearch for more papers by this author First published: 08 April 2022 https://doi.org/10.1002/alr.23003 Potential conflict of interest: S.E.L.: clinical trial funding from Sanofi Aventis Regeneron, GlaxoSmithKline, AstraZeneca, and OptiNose, and participated on advisory boards for GlaxoSmithKline, AstraZeneca, Sanofi Aventis, Regeneron, Genentech, and Novartis; J.A.M: clinical trial salary support from Sanofi Aventis Regeneron, GlaxoSmithKline, AstraZeneca, Genentech, and Optinose; T.M.L: research funding from Regeneron and GlaxoSmithKline, and participated on advisory boards for Sanofi-Aventis Regeneron, GlaxoSmithKline, and AstraZeneca. View this article online at wileyonlinelibrary.com. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Early ViewOnline Version of Record before inclusion in an issue RelatedInformation" @default.
• W4225133088 created "2022-05-01" @default.
• W4225133088 creator A5008669417 @default.
• W4225133088 creator A5009765613 @default.
• W4225133088 creator A5018455097 @default.
• W4225133088 creator A5023665827 @default.
• W4225133088 creator A5030173913 @default.
• W4225133088 creator A5064368662 @default.
• W4225133088 creator A5066823933 @default.
• W4225133088 creator A5072790450 @default.
• W4225133088 creator A5076664123 @default.
• W4225133088 creator A5078729269 @default.
• W4225133088 creator A5089309574 @default.
• W4225133088 date "2022-04-29" @default.
• W4225133088 modified "2023-10-14" @default.
• W4225133088 title "Inhibiting the type 2 inflammatory pathway with dupilumab is associated with an increase in interleukin‐4 and interleukin‐18 production" @default.
• W4225133088 cites W2077576643 @default.
• W4225133088 cites W2289316671 @default.
• W4225133088 cites W2801587651 @default.
• W4225133088 cites W2973122049 @default.
• W4225133088 cites W4206062280 @default.
• W4225133088 cites W4313308240 @default.
• W4225133088 doi "https://doi.org/10.1002/alr.23003" @default.
• W4225133088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35394682" @default.
• W4225133088 hasPublicationYear "2022" @default.
• W4225133088 type Work @default.
• W4225133088 citedByCount "0" @default.
• W4225133088 crossrefType "journal-article" @default.
• W4225133088 hasAuthorship W4225133088A5008669417 @default.
• W4225133088 hasAuthorship W4225133088A5009765613 @default.
• W4225133088 hasAuthorship W4225133088A5018455097 @default.
• W4225133088 hasAuthorship W4225133088A5023665827 @default.
• W4225133088 hasAuthorship W4225133088A5030173913 @default.
• W4225133088 hasAuthorship W4225133088A5064368662 @default.
• W4225133088 hasAuthorship W4225133088A5066823933 @default.
• W4225133088 hasAuthorship W4225133088A5072790450 @default.
• W4225133088 hasAuthorship W4225133088A5076664123 @default.
• W4225133088 hasAuthorship W4225133088A5078729269 @default.
• W4225133088 hasAuthorship W4225133088A5089309574 @default.
• W4225133088 hasConcept C108516343 @default.
• W4225133088 hasConcept C141071460 @default.
• W4225133088 hasConcept C71924100 @default.
• W4225133088 hasConceptScore W4225133088C108516343 @default.
• W4225133088 hasConceptScore W4225133088C141071460 @default.
• W4225133088 hasConceptScore W4225133088C71924100 @default.
• W4225133088 hasIssue "10" @default.
• W4225133088 hasLocation W42251330881 @default.
• W4225133088 hasLocation W42251330882 @default.
• W4225133088 hasOpenAccess W4225133088 @default.
• W4225133088 hasPrimaryLocation W42251330881 @default.
• W4225133088 hasRelatedWork W1506200166 @default.
• W4225133088 hasRelatedWork W1995515455 @default.
• W4225133088 hasRelatedWork W2048182022 @default.
• W4225133088 hasRelatedWork W2080531066 @default.
• W4225133088 hasRelatedWork W2604872355 @default.
• W4225133088 hasRelatedWork W2748952813 @default.
• W4225133088 hasRelatedWork W2899084033 @default.
• W4225133088 hasRelatedWork W3031052312 @default.
• W4225133088 hasRelatedWork W3032375762 @default.
• W4225133088 hasRelatedWork W3108674512 @default.
• W4225133088 hasVolume "12" @default.
• W4225133088 isParatext "false" @default.
• W4225133088 isRetracted "false" @default.
• W4225133088 workType "article" @default.